Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Raban Jeger , Thomas Nestelberger Added: 3 years ago
Coronary artery disease (CAD) remains a major cause of morbidity and mortality despite major improvements in primary and secondary prevention strategies. Percutaneous coronary intervention (PCI) or surgical revascularisation may be indicated in many patients with acute or stable CAD.1 Since the first coronary intervention using catheter mounted balloons, percutaneous treatment of CAD has evolved… View more
Foreword

Article

Author(s): Simon Kennon Added: 3 years ago
This year’s final issue of Interventional Cardiology Review contains a superb section on the assessment and treatment of calcified coronary artery disease. Five articles commissioned by guest editor Nicolas Van Mieghem cover ‘all you need to know but were too scared to ask’ about this ever-relevant subject. The rest of the issue is evenly split between structural and coronary papers offering, as… View more
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 11 months ago
Join Prof Nicolas Van Mieghem and Dr Joost Daemen, interventional experts from the Thoraxcenter at Erasmus MC in Rotterdam, as they provide a comprehensive preview of the late-breaking trials and studies that will be presented at EuroPCR 2023. In this dynamic episode, they offer valuable insights into the latest developments in interventional clinical and research science. Studies include:… View more
Author(s): Anouar Belkacemi , Pierfrancesco Agostoni , Michiel Voskuil , et al Added: 3 years ago
In the past few decades, major progress has been made in the percutaneous treatment of coronary artery disease. Initially, the emergence of balloon angioplasty offered an alternative option for coronary revascularisation. However, abrupt closure and restenosis caused by elastic recoil, neointimal hyperplasia and late remodelling were major drawbacks of balloon angioplasty.1 The use of drug… View more
Author(s): Upul Wickramarachchi , Simon Eccleshall Added: 3 years ago
Percutaneous coronary interventional techniques and devices have evolved enormously since Gruntzig performed his first coronary angioplasty in 1977. 1 It is now the norm to treat patients with both acute coronary syndrome and stable coronary artery disease with drug-eluting stents. We intend to review the evidence and discuss potential benefits of drug-coated balloon-only angioplasty. These… View more
Author(s): Mohammed Imran Ghare , Alexandra Lansky Added: 3 years ago
Transcatheter aortic valve replacement (TAVR) is an innovative treatment modality for patients with severe symptomatic aortic stenosis (AS). After gaining initial market approval in Europe in 2007 and 4 years later in the US, TAVR continues to make large strides. An estimated 340,000 TAVR procedures have been completed in Europe in the immediate 5 years after approval and a further 10,000… View more